These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9588764)

  • 1. Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication.
    Stöber G; Jatzke S; Heils A; Jungkunz G; Knapp M; Mössner R; Riederer P; Lesch KP
    J Neural Transm (Vienna); 1998; 105(1):101-9. PubMed ID: 9588764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [No association of 141C-ins/del polymorphism in the D2 dopamine receptor gene in schizophrenia].
    Rohrmeier T; Putzhammer A; Sartor H; Knapp M; Albus M; Borrmann-Hassenbach M; Lichtermann D; Wildenauer D; Schwab S; Maier W; Klein HE; Eichhammer P
    Psychiatr Prax; 2003 May; 30 Suppl 2():S212-5. PubMed ID: 14509080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia.
    Ohara K; Nagai M; Tani K; Nakamura Y; Ino A; Ohara K
    Psychiatry Res; 1998 Nov; 81(2):117-23. PubMed ID: 9858029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine D2 receptor 5'-flanking variant, -141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo.
    Pohjalainen T; Någren K; Syvälahti EK; Hietala J
    Pharmacogenetics; 1999 Aug; 9(4):505-9. PubMed ID: 10780270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population.
    Xiao L; Shen T; Peng DH; Shu C; Jiang KD; Wang GH
    J Int Med Res; 2013 Aug; 41(4):1171-8. PubMed ID: 23816932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lack of association between 141C Ins/Del promoter polymorphism of DRD2 gene and schizophrenia].
    Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Hauser J
    Psychiatr Pol; 2002; 36(3):413-9. PubMed ID: 12149917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
    Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
    Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
    Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. -141C insertion/deletion polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in Chinese Han population: Evidence from an ethnic group-specific meta-analysis.
    Zhao X; Huang Y; Chen K; Li D; Han C; Kan Q
    Asia Pac Psychiatry; 2016 Sep; 8(3):189-98. PubMed ID: 26346037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
    Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Ishida M; Furukori H; Kaneko S; Inoue Y; Otani K
    Pharmacogenetics; 2001 Aug; 11(6):545-50. PubMed ID: 11505224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia.
    Arinami T; Gao M; Hamaguchi H; Toru M
    Hum Mol Genet; 1997 Apr; 6(4):577-82. PubMed ID: 9097961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between polymorphisms of dopamine receptors, type D2, and bipolar affective illness in a Polish population.
    Leszczyńska-Rodziewicz A; Hauser J; Dmitrzak-Weglarz M; Skibińka M; Czerski P; Zakrzewska A; Kosmowska M; Rybakowski JK
    Med Sci Monit; 2005 Jun; 11(6):CR289-295. PubMed ID: 15917720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor gene -141C Insertion/Deletion polymorphism in Turkish schizophrenic patients.
    Kurt H; Dikmen M; Basaran A; Yenilmez C; Ozdemir F; Degirmenci I; Gunes HV; Kucuk MU; Mutlu F
    Mol Biol Rep; 2011 Feb; 38(2):1407-11. PubMed ID: 20665240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia.
    Jönsson EG; Nöthen MM; Neidt H; Forslund K; Rylander G; Mattila-Evenden M; Asberg M; Propping P; Sedvall GC
    Schizophr Res; 1999 Nov; 40(1):31-6. PubMed ID: 10541004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association of a functional polymorphism in the dopamine D2 receptor promoter region with bipolar or unipolar affective disorders.
    Furlong RA; Coleman TA; Ho L; Rubinsztein JS; Walsh C; Paykel ES; Rubinsztein DC
    Am J Med Genet; 1998 Sep; 81(5):385-7. PubMed ID: 9754623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [No Association of the - 141C Ins/Del Polymorphism of the Dopamine D2 Receptor with Schizophrenia].
    Rohrmeier T; Putzhammer A; Sartor H; Knapp M; Albus M; Borrmann-Hassenbach M; Lichtermann D; Wildenauer D; Schwab S; Maier W; Klein HE; Eichhammer P
    Psychiatr Prax; 2003 May; 30(Suppl 2):212-215. PubMed ID: 13130378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of schizophrenia with a promoter polymorphism in the dopamine D2 receptor gene].
    Peng DH; Wang GH; Cheng ZL; Zhang DX; Jiang KD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):94-5. PubMed ID: 15696493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study.
    Mihara K; Kondo T; Suzuki A; Yasui N; Ono S; Otani K; Kaneko S
    Psychiatry Res; 2001 Feb; 101(1):33-8. PubMed ID: 11223117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia.
    Funahashi Y; Yoshino Y; Yamazaki K; Ozaki Y; Mori Y; Mori T; Ochi S; Iga JI; Ueno SI
    Psychiatry Res; 2019 Aug; 278():135-140. PubMed ID: 31176829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The -141C Ins/Del and Taq1A polymorphism in the dopamine D2 receptor gene may confer susceptibility to schizophrenia in Asian populations.
    Wang Y; Liu L; Xin L; Fan D; Ding N; Hu Y; Cai G; Wang L; Xia Q; Li X; Yang X; Zou Y; Pan F
    J Clin Neurosci; 2016 Aug; 30():1-7. PubMed ID: 27283386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.